4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-24-000059
COFO and Secretary sold 22,844 shares at an average $17.62 ($402,420)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Schuth Alexander O. · COFO and Secretary
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-02-13 | Sale : show line 1 in the form 10b5-1 | −2,716 | $17.29 | $46,960 | 207,469 | D |
| 2024-02-14 | Sale : show line 2 in the form 10b5-1 | −20,128 | $17.66 | $355,460 | 187,341 | D |
| Open-market sales · 22,844 sh · avg $17.62 · $402,420 | ||||||
Loading xslF345X05/wk-form4_1708049627.xml…